Immunocore Holdings plc - stock earnings

IMCR Quarterly earnings

DateEarningsRevenue
2023Q4 -33.7 million USD 134.6 million USD
2023Q3 2.3 million USD 62.8 million USD
2023Q2 -17.8 million USD 60.3 million USD
2023Q1 -20.7 million USD 55.2 million USD
2022Q4 -20.2 million USD 53.9 million USD
2022Q3 6.9 million USD 45.8 million USD
2022Q2 -7.4 million USD 38.9 million USD
2022Q1 -21.1 million USD 29.5 million USD
2021Q4 -53.3 million USD 8.9 million USD
2021Q3 -40.6 million USD 8.0 million USD
2021Q2 -45.6 million USD 7.9 million USD
2021Q1 -40.0 million USD 11.4 million USD
2020Q4 -25.8 million USD 10.1 million USD
2020Q3 -25.0 million USD 8.6 million USD
2020Q2 -21.3 million USD 9.7 million USD
2020Q1 -23.1 million USD 10.2 million USD
2019Q4 -34.0 million USD 7.4 million USD

IMCR Yearly earnings

DateEarningsRevenue
2023 -70.4 million USD 317.8 million USD
2022 -49.9 million USD 173.9 million USD
2021 -177.9 million USD 35.9 million USD
2020 -101.3 million USD 41.2 million USD
2019 -136.3 million USD 33.7 million USD
2018 -90.9 million USD 30.0 million USD
2017 -48.9 million GBP 14.3 million GBP

IMCR

Price: $58.46

52 week price:
42.21
76.98

Earnings Per Share: -1.43 USD

P/E Ratio: -52.59

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 522338

Market Capitalization: 3.2 billion

Links: